@article{83d2c5c4ccf14a60a41b4fa1301c00cf,
title = "Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma",
author = "Lara Ravanetti and Tamara Dekker and Lihui Guo and Annemiek Dijkhuis and Dierdorp, {Barbara S.} and Zuzana Diamant and Sandrine Florquin and Ren{\'e} Lutter",
note = "Funding Information: We thank David Lau, Wenjin Yang, and Ben Chien (all Foresee Pharmaceuticals Co., Ltd) for sharing their knowledge and expertise on FP‐025. This study was financially supported by Foresee Pharmaceuticals Co., Ltd. Funding Information: L.R. receives funding from Foresee Pharmaceuticals, Chiesi Farmaceutici. Z.D. has received honoraria for serving on advisory boards or as a consultant with ALK, AstraZeneca, Boehringer‐Ingelheim, GSK, HAL‐Allergy, MSD, Sanofi‐Genzyme. She acted as Research Director at QPS‐NL: this institution has received research support from Foresee Pharmaceuticals, Novartis and Patara pharma. R.L. receives funding from Foresee Pharmaceuticals, Chiesi Farmaceutici, Astra Zeneca, MedImmune, GSK. The rest of the authors declare that they have no relevant conflicts of interest.",
year = "2022",
month = sep,
day = "12",
doi = "https://doi.org/10.1111/all.15513",
language = "English",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
}